NSleven,
Agree with that. There is one item in the accompanying slide presentation (and that was referenced in the call) re the explosive ramp up in scripts post Reduce It results that I wonder about.
Why include this? Other than to infuriately remind investors of the good ‘ol’ days and what might have been.
There must be a reason - do they think that the ramp up in Europe has the potential to match this, despite the slow uptake currently? Or is it to assist with their current lawsuit against Hikma, by publicly telling Hikma what they’re on the hook for? IDK, they could do that as part of their legal briefs. They have a duty not to mislead so I’m at a loss as to why include scripts from September 2018 to November 2020. Thoughts?
Market Data 
Markets 
AI
